While many patients with acute severe ulcerative colitis will respond to a short ... Surgery is unavoidable in some cases, but is the treatment of choice in others. While ileal pouch–anal ...

Low-fiber fruits and vegetables, lean proteins, and foods rich in omega-3 fatty acids tend to be easier on an inflamed gut, ...

This study demonstrates an early colon survival advantage for patients treated with infliximab compared to those receiving i.v. cyclosporine for acute severe colitis requiring hospitalization at ...

Microscopic colitis, a form of inflammatory bowel disease, has no cure, but it's possible to enter remission. Learn more here ...

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than ...

Some of these forms of colitis are acute, meaning they come on suddenly. Infectious colitis often improves with treatment. But colitis that is caused by IBD, like Crohn's colitis, is considered ...

Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...

Approximately 15% of patients with ulcerative colitis develop an acute attack of severe colitis, and 30% of these patients require colectomy. Severe ulcerative colitis is therefore considered a ...

Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...